<DOC>
	<DOCNO>NCT01655498</DOCNO>
	<brief_summary>The objective study obtain preliminary efficacy safety data use LivSure System ( call `` Eclipseâ„¢ System '' ) woman fecal incontinence .</brief_summary>
	<brief_title>A Clinical Evaluation Vaginal Bowel Control System Treatment Fecal Incontinence Women ( LIFE )</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>History FI least 6 month Baseline diary requirement min # FI episodes twoweek period Ability manage investigational device insertion removal Successful fitting study device Willing able give write informed consent participate study Chronic rectal , anal pelvic pain Any vaginal prolapse extend beyond plane hymen . Previous rectal pelvic floor surgery within last 12 month ( 24 month case cancer ) Congenital anorectal malformation Chronic watery diarrhea unmanageable drug diet primary cause FI Inflammatory bowel disease Presence vaginal , anal , rectal urethral fistula anastomosis Presence vaginal , rectal bladder tumor Presence open wind tear vagina anus exam Presence history rectovaginal fistula Atrophic vaginal tissue determine symptom visualization Current vaginal urinary infection require treatment History recurrent urinary vaginal infection Subject currently pregnant plan pregnancy next 5 month Concurrent use intravaginal device would interfere LivSure ( call Eclipse ) placement wear Any significant medical condition ( e.g. , significant psychiatric neurological disorder , active alcohol/drug abuse , etc . ) factor investigator believe would interfere study participation and/or increase subject risk</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>fecal incontinence</keyword>
	<keyword>bowel control</keyword>
</DOC>